Navigation Links
Betty Ford Center, Hazelden Foundation Pursue Possible Alliance
Date:6/4/2013

CENTER CITY, Minn., June 4, 2013 /PRNewswire-USNewswire/ -- Hazelden Foundation and Betty Ford Center, leaders in addiction treatment, are pursuing a formal alliance.

(Logo: http://photos.prnewswire.com/prnh/20061128/CGTU038LOGO)

Both Hazelden and Betty Ford offer intensive treatment programs for persons addicted to alcohol and/or other drugs.

The boards of both institutions have approved in principle the concept of a formal alliance between the widely-respected institutions.

According to Hazelden's Board of Trustees Chair Judge Susan Fox Gillis , the 2014 full implementation of the Affordable Care Act (ACA) is one of the principle drivers of the affiliation conversations.

Judge Gillis says the ACA presents the treatment field with both challenges and opportunities.

"The good news is that many more Americans who desperately need help will be eligible to receive quality treatment for their addiction to alcohol or other drugs," she says.  "The challenge will be to pay for that expanded coverage and service.  At this stage it appears that institutionally, only the strong will survive and thrive.  Both Betty Ford and Hazelden are recognized as industry leaders, but the fact is we'd be even stronger if we collaborated on a formal basis."

Betty Ford Center Board of Directors Chair Dr. Mary Pattiz says Hazelden and Betty Ford are natural partners.

"We've been as one since day one," she says. "Before Betty Ford Center opened its doors in October, 1982, we looked to Hazelden.  Our co-founders, First Lady Betty Ford and Ambassador Leonard Firestone , studied what's still referred to as `the Hazelden model.'  It was and is our inspiration, and for more than 30 years we've worked side by side as philosophical partners in providing quality care to alcoholics, addicts, and their families."

At both Betty Ford and Hazelden, the Twelve Steps of Alcoholics Anonymous provide the foundation for treatment protocols, which are abstinence-based. 

Judge Gillis, says one of the top priorities – if not the top priority -- as collaboration discussions move forward, will be ensuring that the extraordinary legacy of Betty Ford continues to be honored.

"Mrs. Ford is a hero to us all," she says. "When she so bravely went public about her own addiction, she put a face on this disease.  She brought this disease out of the closet.  By insisting that half the treatment beds at the center named after her be reserved for women, she also guaranteed that women would no longer be `the forgotten gender.'"

Judge Gillis adds that members of the Ford family are a critical part of the ongoing collaboration conversations. 

The Betty Ford Center, a licensed addiction treatment hospital founded in 1982, is based in Rancho Mirage, California.  In February this year it achieved the 100,000 benchmark; that's how many men, women and children have benefited from its many treatment programs.  Betty Ford Center also offers its unique Children's Program in Denver and Dallas/Ft. Worth, and is in the forefront of teaching medical professionals about the disease of addiction and the promise of treatment.

Hazelden Foundation is a national nonprofit organization founded in 1949.  Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family and professional needs, including substance abuse treatment and continuing care for youth and adults, research, higher education, public education and advocacy and publishing.  It currently has facilities in Minnesota, Oregon, Illinois, New York and Florida.


'/>"/>
SOURCE Hazelden Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Sciences Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
2. Disability days at Reliant Center, August 3-5, 2012
3. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
4. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinsons Disease
5. National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill
6. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
7. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
8. National Patient Advocate Foundations Annual Capitol Hill Briefing Focuses on Patient Access Barriers to Life-Saving Medicines Placed on Specialty Tiers by Commercial Insurance Plans and Medicare
9. Epilepsy Foundation To Present Epilepsy Therapy Project Lifetime Accelerator Award To Henrik Klitgaard, Ph.D., Recognizing Contributions To New Therapies
10. Cardinal Health Foundation Invites Local Non-profit Organizations To Apply For Grants To Prevent Prescription Drug Abuse
11. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocytopenia Market and ... to their offering.       ... ,The latest research Europe Thrombocytopenia Market ... provides comprehensive insights into Thrombocytopenia pipeline ...
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. ... announced a development collaboration with the Australian critical medicine company, Phebra Pty ... schizophrenia. , LAI medicines can offer improved therapeutic benefits over oral formulations, including ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative to long-term ... Since first offering the procedure in April of 2015, Florida Hospital Pepin Heart ...
(Date:5/5/2016)... Kansas (PRWEB) , ... May 05, 2016 , ... ... that some macroalgae can use ultraviolet light A (UV-A) for photosynthesis, researchers Juntian ... of red, green, and brown seaweeds. The pair observed that when photosynthetically active ...
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has ... of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring team ... local girl who died suddenly due to complications from the flu, that they have ...
(Date:5/5/2016)... ... May 05, 2016 , ... The University of Western ... host the 2016 National SACA Leadership Conference on the Portland campus September 23-25. ... officers to come together and develop skills to be future leaders in the ...
Breaking Medicine News(10 mins):